The Scan

A small, early-stage trial of a combination therapy for brain cancer reports favorable responses in two patients, according to the Guardian.

NPR reports that vaccine developers are working on SARS-CoV-2 vaccines that are easier to store or administer than the current crop.

Reuters reports that France is to recommend that people under 55 who received one dose of AstraZeneca's SARS-CoV-2 vaccine receive a different vaccine for their second dose.

The Los Angeles Times reports that current SARS-CoV-2 vaccines may be effective against the viral variant first identified in California.

The New York Times writes that both the World Health Organization team and its critics have suggested additional studies to pursue into the origins of SARS-CoV-2.

The New York Times reports on repeated problems at Emergent BioSolutions' vaccine manufacturing facility.

The president of Massachusetts General Hospital is stepping down, the Boston Globe reports.

According to NPR, England is to begin offering free rapid COVID-19 testing, though critics worry about false positives.

CNN reports the B.1.1.7 SARS-CoV-2 variant has been reported throughout the US, underscoring the race between viral variants and vaccination.

The COVID-19 pandemic has hampered the ability of UK medical charities to raise research funds, the Guardian says.

The Sacramento Bee reports the University of California was recently affected by a cybersecurity attack.